- Home
- Publications
- Publication Search
- Publication Details
Title
Endosialin: from vascular target to biomarker for human sarcomas
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 3, Issue 5, Pages 589-604
Publisher
Future Medicine Ltd
Online
2009-10-09
DOI
10.2217/bmm.09.54
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Classical and Regulatory Functions of C1q in Immunity and Autoimmunity
- (2010) Jinhua Lu et al. Cellular & Molecular Immunology
- High VEGFR-3-positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung Cancer
- (2009) K. Bogos et al. CLINICAL CANCER RESEARCH
- Effective Incorporation of Biomarkers into Phase II Trials
- (2009) L. M. McShane et al. CLINICAL CANCER RESEARCH
- Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers
- (2009) Bagley INTERNATIONAL JOURNAL OF ONCOLOGY
- Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
- (2008) Sven Christian et al. AMERICAN JOURNAL OF PATHOLOGY
- Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2
- (2008) A Ohradanova et al. BRITISH JOURNAL OF CANCER
- Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
- (2008) F Doñate et al. BRITISH JOURNAL OF CANCER
- Clinical trials and biomarker development with molecularly targeted agents and radiotherapy
- (2008) Neesha Dhani et al. CANCER AND METASTASIS REVIEWS
- Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
- (2008) M. Dowsett et al. CLINICAL CANCER RESEARCH
- Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
- (2008) C. Rouleau et al. CLINICAL CANCER RESEARCH
- CD93 and Related Family Members: Their Role in Innate Immunity
- (2008) S. Bohlson et al. CURRENT DRUG TARGETS
- Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K
- (2008) Renate Becker et al. FASEB JOURNAL
- Development of targeted angiogenic medicine
- (2008) S. LOGES et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization
- (2008) Rebecca G. Bagley et al. MICROVASCULAR RESEARCH
- Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma
- (2008) Nicole Simonavicius et al. MODERN PATHOLOGY
- Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
- (2008) R. G. Bagley et al. MOLECULAR CANCER THERAPEUTICS
- Biomarkers in oncology drug development
- (2008) Darren R. Hodgson et al. Molecular Oncology
- Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis
- (2008) D. Gao et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started